Skip to main content
Ensol Biosciences Inc. logo

Ensol Biosciences Inc. — Investor Relations & Filings

Ticker · 140610 ISIN · KR7140610007 KO Manufacturing
Filings indexed 257 across all filing types
Latest filing 2021-03-11 Audit Report / Informat…
Country KR South Korea
Listing KO 140610

About Ensol Biosciences Inc.

https://www.ensolbio.co.kr/eng/

Ensol Biosciences Inc. is a biopharmaceutical company focused on developing innovative drugs for diseases with limited or no therapeutic alternatives. The company leverages a bio big data and AI-driven platform for its research and development activities. A core area of its technology involves Protein-Protein Interaction (PPI)-regulating short peptide drugs, which are designed for local injection to maximize therapeutic effects and minimize systemic side effects through high specificity and a short half-life in the blood. The company's pipeline targets a range of medical unmet needs, including degenerative disc disease, osteoarthritis, cancer, and neurodegenerative disorders like Alzheimer's disease. Key clinical-stage assets include E1K for osteoarthritis (preparing for Phase 3) and C1K, an anticancer combination therapy (Phase 1).

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Ensol Biosciences. It provides a summary of the audit opinion (unqualified/appropriate) and key financial highlights (assets, liabilities, net income) for the fiscal year. Since it is a brief announcement of the audit report submission rather than the full, multi-page audit report document itself, it falls under the category of a Report Publication Announcement. FY 2020
2021-03-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea used when an entity's shareholding in a company crosses a specific threshold (typically 5%). This document details the shareholding changes of 'Tiger Asset Management' in 'Ensol Biosciences'. This falls under the category of Major Shareholding Notification.
2021-03-10 Korean
기타주요경영사항(자율공시)(기술평가 결과)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Ensol Biosciences regarding the results of a 'Technology Assessment' (기술성평가), which is a specific requirement for companies in Korea preparing for an IPO. It is a short, structured disclosure of a material event (자율공시) rather than a full financial report or audit. Since it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2021-03-02 Korean
증권발행결과(자율공시)(제1회 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2021-02-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, put/call options, and the use of proceeds. This falls under the category of capital and financing updates as it relates to the company's capital structure and fundraising activities.
2021-02-05 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used when an entity acquires 5% or more of a company's shares. This falls under the category of Major Shareholding Notification (MRQ).
2021-01-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.